TA
SEM

Tamarack Advisers’s Select Medical SEM Stock Holding History

Tamarack Advisers’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-46,400
Closed -$646K – 44
2023
Q1 		$646K Buy
+46,400
New +$683K 0.24% 31

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Tamarack Advisers's SEM Position: Q2 2023 in Review

Tamarack Advisers sold out of Select Medical (SEM) in Q2 2023, closing a stake of 46,400 shares — an estimated $646K sold.

Tamarack Advisers first reported a position in SEM in Q1 2023 and held it in 1 quarter. The position peaked at $646K in Q1 2023. 226 funds tracked by Wall St. Rank hold SEM as of Q2 2023.

  • Tamarack Advisers reported no remaining Select Medical position as of Q2 2023 after selling out during the quarter.
  • Tamarack Advisers sold 46,400 Select Medical shares in Q2 2023, an estimated $646K.
  • Tamarack Advisers first reported a position in Select Medical in Q1 2023 and held it in 1 quarter.
  • Tamarack Advisers's Select Medical position peaked at $646K in Q1 2023.
  • 226 funds tracked by Wall St. Rank held Select Medical as of Q2 2023.

Based on Tamarack Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.